Thu 3 Dec 2009 | 9:20 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Pharmaceutical Product Development

Pharmaceutical Product Development (PPDI.O) (Nasdaq)
sector: Healthcare . industry: Biotechnology ยท View PPDI on other exchanges
As of  2 Dec 2009
21.59USD
Price Change
-0.07
Percent Change
-0.32%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Richardson, William 56 -- Senior Vice President - Global Business Development
Mario, Ernest 70 2009 Lead Independent Director
Dingivan, Christine 41 2008 Executive Vice President, Chief Medical Officer
Wilkinson, Mike 54 2008 Executive Vice President - Global Clinical Development
Eshelman, Fredric 60 2009 Executive Chairman of the Board
Bondurant, Stuart 78 1994 Director
Frank, Frederick 77 1996 Director
McNeill, John 58 1993 Director
Magnuson, Terry 57 2001 Director
Klema, Catherine 50 2000 Director
Sharbaugh, William 46 2007 Chief Operating Officer
Darazsdi, Daniel 48 2007 Chief Financial Officer, Treasurer, Assistant Secretary
Grange, David 60 2009 Chief Executive Officer, Director